BioNexus Gene Lab Corp. (BGLC) vs Trinseo PLC (TSEOQ)
BioNexus Gene Lab Corp. and Trinseo PLC are both Specialty Chemicals companies. Trinseo PLC is the larger, with a market value of $9.5M against $4.3M — 2.2× the size. Trinseo PLC grew revenue faster over the last twelve months: −8.67% against −67.3%. Trinseo PLC has the higher net margin (−20.1% vs −82.4%) and the higher return on invested capital (0.00% vs −37.2%). Across the 18 metrics below, Trinseo PLC leads on 11 and BioNexus Gene Lab Corp. on 7.
Valuation
Profitability
| Metric | BGLC | TSEOQ | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 12.34% | 7.62% | 29.23% |
| Operating margin | (79.62%) | (7.24%) | 3.63% |
| Net margin | (82.36%) | (20.05%) | 2.89% |
| Free cash flow margin | (27.30%) | (13.31%) | 3.78% |
| Return on equity | (33.66%) | 56.89% | 3.62% |
| Return on assets | (28.38%) | (23.26%) | 0.35% |
| Return on invested capital | (37.16%) | 0.00% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack